![](/cdn/assets/images/search/clock.png)
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Pfizer | LSE:PFZ | London | Ordinary Share | COM STK USD0.05 |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 18.78 | 0.00 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
TIDMPFZ
RNS Number : 3486G
T.Rowe Price Associates
19 November 2015
FORM 8.3
IRISH TAKEOVER PANEL
DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997,
TAKEOVER RULES, 2007 (AS AMENDED)
DEALINGS BY PERSONS WITH INTERESTS IN SECURITIES
REPRESENTING 1% OR MORE
1. KEY INFORMATION Name of person dealing T. ROWE PRICE ASSOCIATES, INC. (Note 1) -------------------------------------- ------------------------------- Company dealt in PFIZER INC -------------------------------------- ------------------------------- Class of relevant security ISIN: US7170811035 to which the dealings being disclosed relate (Note 2) -------------------------------------- ------------------------------- Date of dealing 18 November 2015 -------------------------------------- ------------------------------- 2. INTERESTS, SHORT POSITIONS AND RIGHTS TO SUBSCRIBE
(a) Interests and short positions (following dealing) in the class of relevant security dealt in (Note 3)
Long Short --------------------------------- ------------------ ----------- Number (%) Number (%) --------------------------------- ------------------ ----------- (1) Relevant securities 108,956,991 1.76% --------------------------------- ------------------ ----------- (2) Derivatives (other than options) --------------------------------- ------------------ ----------- (3) Options and agreements to purchase/sell --------------------------------- ------------------ ----------- Total 108,956,991 1.76% --------------------------------- ------------------ -----------
(b) Interests and short positions in relevant securities of the company, other than the class dealt in (Note 3)
Class of relevant security: Long Short -------------------------------- ----------- ----------- Number (%) Number (%) -------------------------------- ----------- ----------- (1) Relevant securities -------------------------------- ----------- ----------- (2) Derivatives (other than options) -------------------------------- ----------- ----------- (3) Options and agreements to purchase/sell -------------------------------- ----------- ----------- Total -------------------------------- ----------- ----------- 3. DEALINGS (Note 4) (a) Purchases and sales Purchase/sale Number of securities Price per unit (Note 5) -------------- --------------------- --------------------- Purchases 1,000 33.051 USD 2,900 33.098 USD 2,200 33.259 USD 210 33.268 USD -------------- --------------------- --------------------- (b) Derivatives transactions (other than options) Product name, Long/short Number of securities Price per unit e.g. CFD (Note 6) (Note 7) (Note 5) -------------- ----------- --------------------- --------------- (c) Options transactions in respect of existing securities (i) Writing, selling, purchasing or varying Product name, Writing, Number of Exercise Type, Expiry Option e.g. call selling, securities price e.g. American, date money option purchasing, to which European paid/received varying the option etc. per unit etc. relates (Note (Note 5) 7) -------------- ------------- --------------- --------- ---------------- ------- --------------- (ii) Exercising Product name, e.g. Number of securities Exercise price per call option unit (Note 5) ------------------- --------------------- ------------------- (d) Other dealings (including new securities) (Note 4) Nature of transaction Details Price per unit (if (Note 8) applicable) (Note 5) ---------------------- -------- ------------------- 4. OTHER INFORMATION
Agreements, arrangements or understandings relating to options or derivatives
Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated. ------------------------------------------------------------- None ------------------------------------------------------------- Is a Supplemental Form 8 attached? (Note 9) NO Date of disclosure 19 November 2015 --------------------------------------------- ----------------- Contact name Gary Greb --------------------------------------------- ----------------- Telephone number 001 410 345 2527 --------------------------------------------- ----------------- If a connected EFM, name of offeree/offeror with which connected --------------------------------------------- ----------------- If a connected EFM, state nature of connection (Note 10) --------------------------------------------- -----------------
This information is provided by RNS
The company news service from the London Stock Exchange
END
RETUKAVRVRAAAAA
(END) Dow Jones Newswires
November 19, 2015 10:13 ET (15:13 GMT)
1 Year Pfizer Chart |
1 Month Pfizer Chart |
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions